LGB Adults Are More Likely to Binge Drink Than Their Non-LGB Counterparts

LGB Adults Are More Likely to Binge Drink Than Their Non-LGB Counterparts

Thursday, June 23, 2022 - 11:30am

CAMPAIGN: Alkermes Medicines & Focus: Addiction

CONTENT: Multimedia with summary

A survey by the The National Institute on Drug Abuse (NIDA) showed that 32% of lesbian, gay and bisexual adults reported binge drinking versus 26% of non-LGB adults. To learn more about findings from the study click here: https://bit.ly/3mp23ys

About Alkermes

Alkermes plc is a fully-integrated, global biopharmaceutical company developing innovative medicines in the fields of neuroscience and oncology. The company has a portfolio of proprietary commercial products focused on alcohol dependence, opioid dependence, schizophrenia and bipolar I disorder, and a pipeline of product candidates in development for neurodegenerative disorders and cancer. Headquartered in Dublin, Ireland, Alkermes plc has an R&D center in Waltham, Massachusetts; a research and manufacturing facility in Athlone, Ireland; and a manufacturing facility in Wilmington, Ohio. For more information, please visit Alkermes' website at www.alkermes.com.